Arcadia Biosciences, Inc.
RKDA
$3.46
$0.20196.21%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 4.24M | 6.58M | 8.11M | 8.50M | 11.64M |
Total Receivables | 3.07M | 2.71M | 2.60M | 760.00K | 506.00K |
Inventory | 904.00K | 835.00K | 978.00K | 1.83M | 837.00K |
Prepaid Expenses | 931.00K | 521.00K | 537.00K | 535.00K | 807.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 96.00K | 70.00K | 212.00K | 15.00K | 1.18M |
Total Current Assets | 9.24M | 10.71M | 12.43M | 11.64M | 14.97M |
|
|||||
Total Current Assets | 9.24M | 10.71M | 12.43M | 11.64M | 14.97M |
Net Property, Plant & Equipment | 178.00K | 361.00K | 567.00K | 1.02M | 862.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 39.00K | 39.00K | 39.00K | 39.00K | 39.00K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 4.06M | 4.13M | 4.33M | 3.34M | 3.83M |
Total Assets | 13.52M | 15.24M | 17.37M | 16.05M | 19.71M |
|
|||||
Total Accounts Payable | 703.00K | 1.69M | 1.56M | 1.73M | 485.00K |
Total Accrued Expenses | 1.22M | 30.00K | 80.00K | 75.00K | 1.40M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 155.00K | 346.00K | 563.00K | 801.00K | 852.00K |
Total Finance Division Other Current Liabilities | 483.00K | 260.00K | 495.00K | 270.00K | 854.00K |
Total Other Current Liabilities | 483.00K | 260.00K | 495.00K | 270.00K | 854.00K |
Total Current Liabilities | 2.56M | 2.33M | 2.70M | 2.88M | 3.59M |
|
|||||
Total Current Liabilities | 2.56M | 2.33M | 2.70M | 2.88M | 3.59M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | 11.00K | 21.00K | 155.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 4.73M | 2.76M | 3.09M | 2.66M | 3.26M |
Total Liabilities | 7.29M | 5.09M | 5.80M | 5.56M | 7.00M |
|
|||||
Common Stock & APIC | 285.10M | 284.98M | 284.83M | 284.72M | 284.58M |
Retained Earnings | -278.88M | -274.81M | -273.20M | -274.26M | -271.84M |
Treasury Stock & Other | -- | 117.00K | 81.00K | 161.00K | 101.00K |
Total Common Equity | 6.22M | 10.29M | 11.70M | 10.62M | 12.84M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 6.22M | 10.29M | 11.70M | 10.62M | 12.84M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -138.00K | -138.00K | -138.00K | -138.00K |
Total Equity | 6.22M | 10.15M | 11.57M | 10.48M | 12.70M |
|